$NVLX According to the American cancer Society, in the US

New Post Public Reply Private Reply Replies (0) Message Board
Tandrel
$NVLX According to the American cancer Society, in the US alone, approximately 45,000 new cases of pancreatic cancer are expected to be diagnosed this year and about 38,000 people are predicted to die from the disease; it is the leading cause of cancer deaths in the US and worldwide. Often pancreatic cancer is not diagnosed until it has reached an advanced stage. By this time, the cancer cannot be removed surgically, is often resistant to radiation therapy or chemotherapy, and has spread (metastasized) to other organs in the body. Because of this, the average survival of patients with advanced, inoperable pancreatic cancer is given in terms of weeks or months, not years.Nuvilex’s pancreatic cancer treatment consists of the use of a proprietary cellulose-based live-cell encapsulation technology together with the long-known and widely used anticancer drug ifosfamide.In a Phase I/II open-label, prospective, single-arm clinical trial, the live-cell encapsulation/ifosfamide combination was used to treat patients with advanced, inoperable pancreatic cancer. Fifty-one patients were originally “screened” for the trial; of these, 17 were enrolled in the study. Other patients were excluded from enrollment for therapy because of previous chemotherapy, previous pancreatic surgery, poor overall health, unwillingness to participate, or death prior to the start of the trial. Of the 17 patients initially enrolled in the study, 14 were ultimately treated. Results obtained in the clinical trial were compared with historical data for gemcitabine and included: median survival time of 44 weeks (after diagnosis) with the cell encapsulation/ifosfamide treatment as compared to 28 weeks with gemcitabine; doubling of the one-year survival rate – 36% with our treatment vs. 18% with gemcitabine; tumor volume was reduced 25-50% in 4 of the 14 treated patients and remained stable in the remaining patients; no serious drug-related side effects with the encapsulated cell/ifosfamide treatment whereas serious and very serious side effects were reported with gemcitabine; the lack of serious side effects using our treatment is probably related to the use of “lower than normal” doses of ifosfamide; limited side effects and reduced cancer pain intensity led to a generally increased ‘quality of life” for the majority of patients. In a “worst case” scenario, some clinical benefit was seen in 50% of patients and in a “best case” scenario, this number increased to 71%; none of the patients who experienced a clinical benefit required and increase in their pain medication.

PharmaCyte Biotech Inc. (PMCB) Stock Research Links

PMCB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Spire's Year-End Call: Eyes on Earnings & Guidance

Updated Category News Views 1

Anticipation Builds for Spire's Upcoming Earnings Call If you're keen on natural gas and the energy sector, keep a firm grip on your coffee cup because Spire Inc. (NYSE: SR) is about to spill the beans on their fiscal 2026 financials. Mark your calendars for November 17. Whether you're tuning in via phone or hitching a ride on the webcast, you're in for an earful. Time...

Continue Reading
Encompass Health: Leader in Rehabilitation Again in 2026

Updated Category News Views 1

Pinnacle of Rehab: Encompass Health's Notable Streak You know, in a world where healthcare accolades fly around like confetti, Encompass Health Corp's persistence in being named America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek for the seventh straight year is something to chew on. The fact that a record 78 of its hospitals dotted across 32 states...

Continue Reading
Understanding Truck Accident Settlements in Memphis

Updated Category News Views 2

Delving into Truck Accident Settlement Timelines Out there in Memphis, timing a truck accident settlement isn't exactly like clockwork work. When it comes to getting your compensation, the timeline varies as widely as a duck hunting trip—sometimes you come home with a basketful, sometimes it’s empty. It might be a quick couple of months or drag on past a year, and...

Continue Reading
Taiwan Excellence Sparks Smart Automotive Innovation at SEMA

Updated Category News Views 1

Taiwan's making waves, folks, and it's not your everyday splash in the automotive pool. At SEMA 2026, Taiwan Excellence Pavilion is the place to be with its array of intelligent automotive solutions. This ain't just your run-of-the-mill car show gimmickry—it's the future rolling in real-time. Driving Innovation: From Components to Smart Systems The name of the game is...

Continue Reading
New JPA Aims to Energize Inland Empire's Water Supply

Updated Category News Views 13

Fresh Steps in San Bernardino's Infrastructure Strategy Here's a twist for you: public agencies in San Bernardino County decided enough with the same old, same old and cooked up a new joint powers authority (JPA). They call it the San Bernardino Water and Power Authority, which sounds snappy enough for a meeting room nameplate, I reckon. Who's Steering the Ship? Leading...

Continue Reading
Artificial Stone Silicosis: A Silent Threat Unveiled

Updated Category News Views 1

The Harsh Reality Behind Artificial Stone You're slicing into your steak at a fancy dinner, and for a moment, you marvel at the countertop beneath your dish—a smooth, sleek surface that's likely made of artificial stone. But beneath that lustrous facade lurks a silent killer affecting those fabricating these countertops every day. Voices from the Frontline Recently,...

Continue Reading
VISTAR Oakland Workers Join Teamsters for Unity

Updated Category News Views 3

Warehouse Workers Break Free from the Shackles Ever had that feeling, where enough is enough? That's where 37 warehouse workers at VISTAR find themselves, shaking off the dust and signing up with Teamsters Local 853. This ain't just a fleeting wind of change; it's the whole damn storm. Turning Points and Union Victories Think about it. This move by the VISTAR warehouse...

Continue Reading
AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Updated Category News Views 11

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Continue Reading
Noé Hinojosa Jr. Honored for Leadership in Business

Updated Category News Views 4

From Bonds to Ballgames: Hinojosa's Impact Listen up, because this one’s more than just another accolade on a shelf. Noé Hinojosa Jr., a big gun over at TRB Securities, is getting the 2026 Hispanic Business Salute Award, and it's a doozy. Awarded by all the big wigs—UPS, NBC 5, Telemundo 39, and the Dallas Cowboys—this isn't a small pat on the back. It's a full-on...

Continue Reading
Ball Corp's Leadership Shuffle Aims for Strategic Gains

Updated Category News Views 1

Leadership Changes in the Midst of Market Challenges You don't need a crystal ball to see that leadership changes can signal either turmoil or opportunity. Ball Corporation, a titan in the realm of aluminum packaging, is experiencing a shake-up at the top of its beverage packaging business units. With Carey Causey stepping into the role for North and Central America, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Asurity Expands Sales Team with Experienced Leaders for Growth

Updated Category News Views 91

Asurity Expands Sales Leadership In an exciting development in the business sector, Asurity Technologies, LLC is enhancing its sales leadership team by bringing on board two distinguished professionals. This strategic move is aimed at driving growth and forging stronger relationships within the mortgage and consumer lending industries. Meet the New Leaders: Kelly Booth...

Continue Reading
Creatd, Inc.'s Q1 2025 Report Shows Remarkable Growth

Updated Category News Views 213

Creatd, Inc. Marks a Transformative Q1 2025 Financial Performance NEW YORK — Creatd, Inc. (OTC: CRTD), a dynamic holding company dedicated to acquiring synergistic businesses, recently unveiled its impressive financial results for the first quarter of 2025. The disclosures reflect a pivotal moment for the company, highlighting continued growth and strategic advancements...

Continue Reading
Palatin Technologies Shows Promising Growth in Obesity Treatments

Updated Category News Views 126

Palatin Technologies Advances in the Obesity Treatment Sector Palatin Technologies, Inc. is marking significant advancements in its efforts to combat obesity by enhancing its research and development programs. This biopharmaceutical company focuses on innovative therapies aimed at modulating the melanocortin receptor (MCR) system, which is instrumental in managing...

Continue Reading
Horizon Organic's Growing Years® Milk Campaign Empowers Parents

Updated Category News Views 239

Horizon Organic Expands Its Campaign for Growing Families As parents approach their child's first birthday, managing the transition from breastmilk or formula to dairy milk can be stressful. To alleviate this concern, Horizon Organic has launched an exciting initiative encompassing expert support and engaging giveaways. This Milk Means Business: A Holistic Approach...

Continue Reading
Atlassian Set to Unveil First Quarter FY 2025 Results Soon

Updated Category News Views 76

Atlassian's First Quarter Financial Results Announcement Atlassian Corporation (NASDAQ: TEAM), renowned for empowering teams through innovative software solutions, is gearing up to share its financial results for the first quarter of fiscal year 2025. This pivotal announcement will be made after the market closes, revealing insights from the quarter that ended on...

Continue Reading